- Kathleen Sebelius cites pharmacists' importance as Rite Aid CEO introduces Obamacare resource program
- Rite Aid posts third consecutive quarterly profit as company expands Wellness+
- New Rite Aid group VP pharmacy initiatives and clinical services to oversee Wellness Ambassador program
- Senate passes Drug Quality and Security Act
- Rite Aid appoints pharmacy division executive as group VP managed care
CAMP HILL, Pa. — Rite Aid on Thursday posted sales of $6.2 billion, down 2.3%, for its third quarter ended Nov. 27. Same-store sales for the period declined 1.3%, representing flat front-end sales and a pharmacy comparable sales decline of 1.9%.
For the five-week period ended Nov. 27, which includes Black Friday sales, front-end sales were up 1.3% while pharmacy same-store sales, which included an approximate 248 basis points negative impact from new generic introductions, declined 2.5%. Overall monthly comps fell 1.3%.
Over the course of the quarter, prescription revenue represented 68.3% of total drug store sales, and third-party prescription revenue was 96.2% of pharmacy sales.